Ironwood Pharmaceuticals, Inc. (IRWD)
4.81
-0.04
(-0.82%)
USD |
NASDAQ |
Nov 13, 10:20
Ironwood Pharmaceuticals EPS Diluted (Quarterly) : 0.3558 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.3558 |
| June 30, 2026 | 0.3068 |
| March 31, 2026 | 0.2446 |
| December 31, 2025 | -0.014 |
| September 30, 2025 | 0.2294 |
| June 30, 2025 | 0.1374 |
| March 31, 2025 | -0.2322 |
| December 31, 2024 | 0.0141 |
| September 30, 2024 | 0.0228 |
| June 30, 2024 | -0.0054 |
| March 31, 2024 | -0.0264 |
| December 31, 2023 | -0.007 |
| September 30, 2023 | 0.082 |
| June 30, 2023 | -6.837 |
| March 31, 2023 | 0.2508 |
| December 31, 2022 | 0.2639 |
| September 30, 2022 | 0.2788 |
| June 30, 2022 | 0.2066 |
| March 31, 2022 | 0.2047 |
| December 31, 2021 | 0.2498 |
| September 30, 2021 | 0.338 |
| June 30, 2021 | 2.393 |
| March 31, 2021 | 0.2459 |
| December 31, 2020 | 0.2675 |
| September 30, 2020 | 0.2148 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.1576 |
| March 31, 2020 | 0.0209 |
| December 31, 2019 | 0.3031 |
| September 30, 2019 | 0.132 |
| June 30, 2019 | 0.0788 |
| March 31, 2019 | -0.3826 |
| December 31, 2018 | -0.1005 |
| September 30, 2018 | -1.138 |
| June 30, 2018 | -0.3245 |
| March 31, 2018 | -0.29 |
| December 31, 2017 | 0.08 |
| September 30, 2017 | -0.22 |
| June 30, 2017 | -0.30 |
| March 31, 2017 | -0.36 |
| December 31, 2016 | -0.09 |
| September 30, 2016 | -0.23 |
| June 30, 2016 | -0.15 |
| March 31, 2016 | -0.09 |
| December 31, 2015 | -0.0983 |
| September 30, 2015 | -0.33 |
| June 30, 2015 | -0.34 |
| March 31, 2015 | -0.24 |
| December 31, 2014 | -0.27 |
| September 30, 2014 | -0.30 |
| June 30, 2014 | -0.44 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xencor, Inc. | 0.5033 |
| Viking Therapeutics, Inc. | -1.552 |
| IDEAYA Biosciences, Inc. | -1.222 |
| BioMarin Pharmaceutical, Inc. | -0.6345 |
| Inovio Pharmaceuticals, Inc. | -0.4989 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 59.84M |
| Revenue (Quarterly) | 133.04M |
| Total Expenses (Quarterly) | 73.20M |
| Enterprise Value | 1.053B |
| Gross Profit Margin (Quarterly) | 99.66% |
| Profit Margin (Quarterly) | 44.98% |
| Earnings Yield | 18.57% |
| Operating Earnings Yield | 31.48% |
| Normalized Earnings Yield | 18.54 |